Skip to main content

breast cancer

Triple-negative breast cancer drug therapy shows promise

Mar. 12, 2020—Researchers from Vanderbilt-Ingram Cancer Center (VICC) discovered a role for MYCN in triple-negative breast cancer (TNBC), a particularly aggressive form of the disease, and identified a potential intervention for further clinical investigation.

Read more


Breast cancer study may help predict treatment response

Feb. 27, 2020—Researchers at VUMC are reporting another advance in the understanding and treatment of triple-negative breast cancer, which is particularly aggressive and difficult to treat.

Read more


Rafat receives Young Investigator Grant from Breast Cancer Alliance

Feb. 19, 2020—The two-year, $125,000 award will allow Marjan Rafat and her research group to investigate how radiation influences tumor and immune cell recruitment in triple negative breast cancer.

Read more


Imaging breast cancer cell size

Feb. 10, 2020—A noninvasive MRI approach assesses breast tumor cell size and could be a useful way to evaluate early response to neoadjuvant therapy.

Read more


HDL-cholesterol and breast cancer risk

Jan. 23, 2020—Genetic analyses suggest that high circulating HDL-cholesterol levels may increase breast cancer risk — a surprising finding since increased HDL-cholesterol is thought to be healthy.

Read more


Another way to detect lymphedema

Oct. 22, 2019—Early detection of lymphedema, which occurs in 20% of patients following breast cancer treatment, may improve therapeutic options for patients.

Read more


Study finds men have higher mortality rate after breast cancer diagnosis

Oct. 17, 2019—A new study shows men with breast cancer are more likely to die than their female counterparts, across all stages of disease.

Read more


Health Plus promotes breast cancer awareness at VU Benefits Open House Oct. 23

Oct. 8, 2019—Health Plus will promote breast cancer awareness at the VU Benefits Open House on Wednesday, Oct. 23.

Read more


Think Pink! Breast Cancer Awareness Expo is Oct. 2

Sep. 19, 2019—The Think Pink! Breast Cancer Awareness Expo is scheduled from 11 a.m. to 1 p.m. Wednesday, Oct. 2, in the Light Hall North Lobby. Visit the expo to learn about breast cancer prevention, screenings and more.

Read more


A “rheostat” for cancer signals

Aug. 27, 2019—Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells.

Read more


Biomarkers of DNA methylation can be a predictor of breast cancer risk

Jun. 26, 2019—Biomarkers of DNA methylation, which regulate gene expression, can be a predictor of breast cancer risk.

Read more


Like racecars and geese, cancer cells draft their way to new tumor sites

Mar. 25, 2019—The finding gives a boost to the field of metabolomics, the next big thing in fighting cancer. It can complement immunotherapies, which use the body’s natural defenses to kill cancer cells.

Read more


VIEW MORE EVENTS >